Effect of tetrahydroberberine on blockade of pre- and postsynaptic dopamine receptors
Wang, X.L.; Jin, G.Z.; Yu, L.P.; Li, J.H.
Zhongguo Yao Li Xue Bao 3(2): 73-77
1982
ISSN/ISBN: 0253-9756 PMID: 6214151 Document Number: 194289
Document emailed within 1 workday
Related Documents
Andén, N.E.; Grabowska-Andén, M. 1980: Drug effects on pre- and postsynaptic dopamine receptors Advances in Biochemical Psychopharmacology 24: 57-64Berga, P.; Beckett, P.R.; Roberts, D.J. 1979: Antagonism of pre- and postsynaptic dopamine receptors by clebopride and related orthopramides Archivos de Farmacologia y Toxicologia 5(3): 144-146
Idova, G.V.; Cheĭdo, M.A.; Zhukova, E.N. 2006: Effect of the activation and blockade of D2 dopamine receptors on the immune response in mice with different types of social behavior Rossiiskii Fiziologicheskii Zhurnal Imeni I.M. Sechenova 92(5): 552-559
Fuller, R.W.; Clemens, J.A.; Hynes, M.D. 1982: Degree of selectivity of pergolide as an agonist at presynaptic versus postsynaptic dopamine receptors: implications for prevention or treatment of tardive dyskinesia Journal of Clinical Psychopharmacology 2(6): 371-375
Jeste, D.V.; Wyatt, R.J. 1981: Dogma disputed: is tardive dyskinesia due to postsynaptic dopamine receptor supersensitivity? Journal of Clinical Psychiatry 42(12): 455-457
Berzétei, I.P.; Bagdy, E.; Hardy, M.; Borsy, J. 1985: The effect of GYKI-32 887 on dopamine (D2) and serotonin (5-HT1 and 5-HT2) receptors Polish Journal of Pharmacology and Pharmacy 37(3): 237-242
Przesmycki, K.; Kleinrok, Z. 1976: The effect of bradykinin on central dopamine receptors Polish Journal of Pharmacology and Pharmacy 28(6): 673-678
Ogawa, N.; Asanuma, M.; Takayama, H.; Sato, H.; Nukina, I. 1990: Effect of flunarizine hydrochloride on striatal D-2 dopamine receptors Rinsho Shinkeigaku 30(11): 1221-1226
Criswell, H.; Mueller, R.A.; Breese, G.R. 1988: Assessment of purine-dopamine interactions in 6-hydroxydopamine-lesioned rats: evidence for pre- and postsynaptic influences by adenosine Journal of Pharmacology and Experimental Therapeutics 244(2): 493-500
Hyttel, J.; Christensen, A.V. 1983: Biochemical and pharmacological differentiation of neuroleptic effect on dopamine D-1 and D-2 receptors Journal of Neural Transmission. Supplementum 18: 157-164
Puri, S.K.; Reddy, C.; Lal, H. 1973: Blockade of central dopaminergic receptors of morphine: effect of haloperidol, apomorphine or benztropine Research Communications in Chemical Pathology and Pharmacology 5(2): 389-401
Dwoskin, L.P.; Zahniser, N.R. 1986: Robust modulation of [3H]dopamine release from rat striatal slices by D-2 dopamine receptors Journal of Pharmacology and Experimental Therapeutics 239(2): 442-453
Sternitzke, N.; Schieffer, H.; Hoffmann, W.; Bette, L. 1976: Modification of the cardiovascular-dynamic effect of Akrinor following the blockade of adrenergic beta receptors with propranolol Verhandlungen der Deutschen Gesellschaft für Innere Medizin 82 Pt 2: 1132-1135
Janczewska, H.; Bogdański, W.; Trzebski, A. 1980: Influence of alpha and beta adrenergic receptors blockade on the adrenolytic effect of muscular work Acta Physiologica Polonica 31(5): 469-474
Tadori, Y.; Kobayashi, H. 2014: The therapeutic plasma concentrations of antiparkinson dopamine agonists and their in vitro pharmacology at dopamine receptors Nihon Shinkei Seishin Yakurigaku Zasshi 34(5-6): 127-132
Katzman, R.; Makman, M.H.; Ahn, H.S.; Mishra, R.K.; Gardner, E. 1977: Effects of drugs and lesions on dopamine-stimulated adenylate cyclase: evidence for different classes of dopamine receptors Transactions of the American Neurological Association 102: 76-79
Kohli, J.D.; Weder, A.B.; Goldberg, L.I.; Ginos, J.Z. 1980: Structure activity relationships of N-substituted dopamine derivatives as agonists of the dopamine vascular and other cardiovascular receptors Journal of Pharmacology and Experimental Therapeutics 213(2): 370-374
Cuenca, E. 1981: Role of postsynaptic noradrenergic receptors in the mechanism of action of antidepressants L'Encephale 7(4 Suppl): 397
Schuurkes, J.A.; Van Nueten, J.M. 1981: Effects of dopamine and its antagonist domperidone cannot be explained by an effect on alpha 1-adrenergic receptors Archives Internationales de Pharmacodynamie et de Therapie 250(2): 324-327
Saller, C.F.; Czupryna, M.J.; Salama, A.I. 1990: 5-HT2 receptor blockade by ICi 169,369 and other 5-HT2 antagonists modulates the effects of D-2 dopamine receptor blockade Journal of Pharmacology and Experimental Therapeutics 253(3): 1162-1170